116 related articles for article (PubMed ID: 1391490)
1. Effects of X-linked hemoglobin on in-vitro platelet function.
Reiss RF; Caballero R; Hess J
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):651-5. PubMed ID: 1391490
[TBL] [Abstract][Full Text] [Related]
2. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats.
Abassi Z; Kotob S; Pieruzzi F; Abouassali M; Keiser HR; Fratantoni JC; Alayash AI
J Lab Clin Med; 1997 Jun; 129(6):603-10. PubMed ID: 9178726
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of diaspirin cross-linked human hemoglobin solutions.
Estep TN; Gonder J; Bornstein I; Aono F
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):603-9. PubMed ID: 1391483
[TBL] [Abstract][Full Text] [Related]
4. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin.
D'Agnillo F; Alayash AI
Adv Drug Deliv Rev; 2000 Feb; 40(3):199-212. PubMed ID: 10837790
[TBL] [Abstract][Full Text] [Related]
5. Morphologic alterations in rat retina after hypervolemic infusion of cross-linked hemoglobin.
Schuschereba ST; Clifford CB; Vargas JA; Bunch D; Bowman PD
Biomater Artif Cells Artif Organs; 1990; 18(2):299-307. PubMed ID: 2369652
[TBL] [Abstract][Full Text] [Related]
6. Morphologic effects of hypervolemic administration of DBBF hemoglobin in the rat.
Clifford CB; Wessels DA; Smith CD
Biomater Artif Cells Artif Organs; 1990; 18(2):321-8. PubMed ID: 2369654
[TBL] [Abstract][Full Text] [Related]
7. Determination of aspirin responsiveness by use of whole blood platelet aggregometry.
Ivandic BT; Giannitsis E; Schlick P; Staritz P; Katus HA; Hohlfeld T
Clin Chem; 2007 Apr; 53(4):614-9. PubMed ID: 17332149
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin-based oxygen carriers do not alter platelet functions: study of three chemically modified hemoglobin solutions.
Toussaint M; Latger-Cannard V; Caron A; Lecompte T; Vigneron C; Menu P
Intensive Care Med; 2003 Jan; 29(1):62-8. PubMed ID: 12528024
[TBL] [Abstract][Full Text] [Related]
9. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
[TBL] [Abstract][Full Text] [Related]
10. Intravascular circulation and distribution of human 51Cr-DBBF stroma-free hemoglobin.
Dittmer J; Ichikura T; Pivacek LE; Giorgio A; Prusty S; Valeri CR
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):751-5. PubMed ID: 1391507
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics of a hemoglobin crosslinking reaction.
Pavlik PA; Boyd MK; Olsen KW
Biopolymers; 1996 Oct; 39(4):615-8. PubMed ID: 8837523
[No Abstract] [Full Text] [Related]
12. Effects of o-raffinose-polymerized human hemoglobin on coronary tone and cardiac function in isolated hearts.
Vogel WM; Cassidy G; Valeri CR
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):673-7. PubMed ID: 1391494
[No Abstract] [Full Text] [Related]
13. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies.
Nelson D; Azari M; Brown R; Burhop K; Bush S; Catarello J; Chuang H; Downing C; Estep T; Loewen A
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):423-7. PubMed ID: 1391458
[TBL] [Abstract][Full Text] [Related]
14. Coronary vasoconstrictor activity of purified and modified human hemoglobin.
Macdonald VW; Winslow RM; Marini MA; Klinker MT
Biomater Artif Cells Artif Organs; 1990; 18(2):263-82. PubMed ID: 2369650
[TBL] [Abstract][Full Text] [Related]
15. Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following severe hemorrhage in the rat.
Malcolm D; Kissinger D; Garrioch M
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):495-7. PubMed ID: 1391469
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and properties of polymerized, diaspirin cross-linked hemoglobins.
Nelson D; Hai T; Srnak A; Ebeling A; Kunas G; Catarello J; Burhop K
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):253-8. PubMed ID: 1391439
[TBL] [Abstract][Full Text] [Related]
17. Hemolink, an o-raffinose cross-linked haemoglobin-based oxygen carrier, does not affect activation and function of human platelets in whole blood in vitro.
Leytin V; Mazer D; Mody M; Garvey B; Freedman J
Br J Haematol; 2003 Feb; 120(3):535-41. PubMed ID: 12580976
[TBL] [Abstract][Full Text] [Related]
18. Platelet function in baboons and humans - A comparative study of whole blood using impedance platelet aggregometry (Multiplate®).
Ponschab M; van Griensven M; Heitmeier S; Laux V; Schlimp CJ; Calatzis A; Bahrami S; Redl H; Schöchl H
Thromb Res; 2016 Nov; 147():115-121. PubMed ID: 27736703
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry.
Albanyan A; Al-Musa A; AlNounou R; Al Zahrani H; Nasr R; AlJefri A; Saleh M; Malik A; Masmali H; Owaidah T
Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
